Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source
von Falkenhausen AS, Feil K, Sinner MF, Schoenecker S, Mueller J, Wischmann J, Eiffener E, Clauss S, Poli S, Poli K, Zuern CS, et al. (2022)
Annals of Neurology.
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
von Falkenhausen, Aenne S.;
Feil, Katharina;
Sinner, Moritz F.;
Schoenecker, Sonja;
Mueller, Johanna;
Wischmann, Johannes;
Eiffener, Elodie;
Clauss, Sebastian;
Poli, Sven;
Poli, Khouloud;
Zuern, Christine S.;
Ziemann, Ulf
Alle
Alle
Einrichtung
Abstract / Bemerkung
Objective: Approximately 20% of strokes are embolic strokes of undetermined source (ESUS). Undetected atrial fibrillation (AF) remains an important cause. Yet, oral anticoagulation in unselected ESUS patients failed in secondary stroke prevention. Guidance on effective AF detection is lacking. Here, we introduce a novel, non-invasive AF risk assessment after ESUS. Methods: Catch-Up ESUS is an investigator-initiated, observational cohort study conducted between 2018 and 2019 at the Munich University Hospital. Besides clinical characteristics, patients received & GE;72 h digital electrocardiogram recordings to generate the rhythm irregularity burden. Uni- and multivariable regression models predicted the primary endpoint of incident AF, ascertained by standardized follow-up including implantable cardiac monitors. Predictors included the novel rhythm irregularity burden constructed from digital electrocardiogram recordings. We independently validated our model in ESUS patients from the University Hospital Tubingen, Germany. Results: A total of 297 ESUS patients were followed for 15.6 +/- 7.6 months. Incident AF (46 patients, 15.4%) occurred after a median of 105 days (25th to 75th percentile 31-33 days). Secondary outcomes were recurrent stroke in 7.7% and death in 6.1%. Multivariable-adjusted analyses identified the rhythm irregularity burden as the strongest AF-predictor (hazard ratio 3.12, 95% confidence interval 1.62-5.80, p < 0001) while accounting for the known risk factors age, CHA(2)DS(2)-VASc-Score, and NT-proBNP. Independent validation confirmed the rhythm irregularity burden as the most significant AF-predictor (hazard ratio 2.20, 95% confidence interval 1.45-3.33, p < 0001). Interpretation: The novel, non-invasive, electrocardiogram-based rhythm irregularity burden may help adjudicating AF risk after ESUS, and subsequently guide AF-detection after ESUS. Clinical trials need to clarify if high-AF risk patients benefit from tailored secondary stroke prevention.
Erscheinungsjahr
2022
Zeitschriftentitel
Annals of Neurology
ISSN
0364-5134
eISSN
1531-8249
Page URI
https://pub.uni-bielefeld.de/record/2967884
Zitieren
von Falkenhausen AS, Feil K, Sinner MF, et al. Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source. Annals of Neurology. 2022.
von Falkenhausen, A. S., Feil, K., Sinner, M. F., Schoenecker, S., Mueller, J., Wischmann, J., Eiffener, E., et al. (2022). Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source. Annals of Neurology. https://doi.org/10.1002/ana.26545
von Falkenhausen, Aenne S., Feil, Katharina, Sinner, Moritz F., Schoenecker, Sonja, Mueller, Johanna, Wischmann, Johannes, Eiffener, Elodie, et al. 2022. “Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source”. Annals of Neurology.
von Falkenhausen, A. S., Feil, K., Sinner, M. F., Schoenecker, S., Mueller, J., Wischmann, J., Eiffener, E., Clauss, S., Poli, S., Poli, K., et al. (2022). Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source. Annals of Neurology.
von Falkenhausen, A.S., et al., 2022. Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source. Annals of Neurology.
A.S. von Falkenhausen, et al., “Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source”, Annals of Neurology, 2022.
von Falkenhausen, A.S., Feil, K., Sinner, M.F., Schoenecker, S., Mueller, J., Wischmann, J., Eiffener, E., Clauss, S., Poli, S., Poli, K., Zuern, C.S., Ziemann, U., Berrouschot, J., Kitsiou, A., Schaebitz, W.-R., Dieterich, M., Massberg, S., Kaeaeb, S., Kellert, L.: Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source. Annals of Neurology. (2022).
von Falkenhausen, Aenne S., Feil, Katharina, Sinner, Moritz F., Schoenecker, Sonja, Mueller, Johanna, Wischmann, Johannes, Eiffener, Elodie, Clauss, Sebastian, Poli, Sven, Poli, Khouloud, Zuern, Christine S., Ziemann, Ulf, Berrouschot, Jorg, Kitsiou, Alkisti, Schaebitz, Wolf-Rudiger, Dieterich, Marianne, Massberg, Steffen, Kaeaeb, Stefan, and Kellert, Lars. “Atrial Fibrillation Risk Assessment after Embolic Stroke of Undetermined Source”. Annals of Neurology (2022).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 36373166
PubMed | Europe PMC
Suchen in